An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms
about
Apolipoprotein C3 SstI polymorphism and triglyceride levels in Asian IndiansMitogen-activated protein kinase regulates transcription of the ApoCIII gene. Involvement of the orphan nuclear receptor HNF4Increased coronary heart disease in Japanese-American men with mutation in the cholesteryl ester transfer protein gene despite increased HDL levelsAssociations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.Antiretroviral therapy and dyslipidaemia: unlocking the code.Gene polymorphisms associated with non-alcoholic fatty liver disease and coronary artery disease: a concise reviewNeedles in the genetic haystack of lipid disorders: single nucleotide polymorphisms in the microRNA regulomeApolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor alpha activatorsThe genetics of serum lipid responsiveness to dietary interventions.Insulin resistance and cardiovascular disease.Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior.Fibrates downregulate apolipoprotein C-III expression independent of induction of peroxisomal acyl coenzyme A oxidase. A potential mechanism for the hypolipidemic action of fibratesThe expression of type III hyperlipoproteinemia: involvement of lipolysis genesApolipoprotein C3 (-455T>C) polymorphism confers susceptibility to nonalcoholic fatty liver disease in the Southern Han Chinese populationCandidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twinsEvidence of linkage of familial hypoalphalipoproteinemia to a novel locus on chromosome 11q23.Dissociation between APOC3 variants, hepatic triglyceride content and insulin resistance.Association of an APOC3 promoter variant with type 2 diabetes risk and need for insulin treatment in lean persons.A multilocus genotyping assay for candidate markers of cardiovascular disease riskEvidence for consistent intragenic and intergenic interactions between SNP effects in the APOA1/C3/A4/A5 gene cluster.Influence of genetic variants in the apolipoprotein A5 and C3 gene on lipids, lipoproteins, and its association with coronary artery disease in Indians.Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia.Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescentsVariation at the hepatic lipase and apolipoprotein AI/CIII/AIV loci is a major cause of genetically determined variation in plasma HDL cholesterol levels.Multilocus genetic determinants of LDL particle size in coronary artery disease familiesThe implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descent.Determinants of plasma apolipoprotein A-V and APOA5 gene transcripts in humans.Transgenic mouse models of lipoprotein metabolism and atherosclerosisSstI Polymorphism of the Apolipoprotein CIII Gene in Iranian Hyperlipidemic Patients: A Study in Semnan Province.Lipoprotein metabolism in nonalcoholic fatty liver diseaseImpact of genetic polymorphisms on the risk of lipid disorders in patients on anti-HIV therapy.Association of apolipoprotein A1-C3 gene cluster polymorphisms with gallstone disease.Combined hyperlipidemia in transgenic mice overexpressing human apolipoprotein ClComplex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia. Identification of different susceptibility haplotypes.Chylomicronemia due to apolipoprotein CIII overexpression in apolipoprotein E-null mice. Apolipoprotein CIII-induced hypertriglyceridemia is not mediated by effects on apolipoprotein ERetinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids.Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11.Linkage and association between distinct variants of the APOA1/C3/A4/A5 gene cluster and familial combined hyperlipidemia.A rare functional cardioprotective APOC3 variant has risen in frequency in distinct population isolatesLack of association between apolipoprotein C3 gene polymorphisms and risk of nonalcoholic fatty liver disease in a Chinese Han population.
P2860
Q21283798-2D52644B-A388-4FEB-ACCC-9BA4C626F939Q22010768-32087003-EF3A-49F8-BBED-0496B338E7C5Q24562095-AE70A812-D918-4A46-B35C-699C8BDBD334Q25255216-B1EFA78B-09B1-44EF-AD5C-D868E3445C06Q25256933-129ADEAF-8F6E-4E03-9431-BF5E3C75AD4BQ26766459-D997C28A-19CF-4D30-BCCC-5E4C21EF8AF6Q27015035-256819FB-E026-4A40-B13E-72F06496F87BQ28183207-FF3EA00D-E3D6-450B-884B-2B62F01B612FQ33644526-48F48746-4CED-448B-878E-1A000B609534Q34011027-3C897A84-A5F2-41E7-A564-4FFC3BCE0E38Q34141163-0149548D-0954-4D63-9997-5F009C23F4D5Q34201490-897A1106-083A-4601-BFD6-4DBCF07C7959Q34326186-6B76E69D-8B16-4E48-BB3B-B1033B634F6CQ34326735-CF900FBB-951E-49E5-B30A-06089F4D2757Q34384470-71D96403-5F81-47ED-AE31-0D64104B3EB0Q34390571-7A144094-2E36-427E-BB63-2151E2F80631Q34674263-6D1C95AB-393D-410B-B19B-54BE16B681BBQ34940128-6E44DE91-D56B-4ACC-8B25-97B0BD6D208DQ35024990-AA6D96FA-9BD2-4D40-BB67-C8FFFDEF932CQ35222415-0416DB60-6448-4932-89A2-82A9D51CA9E6Q35263542-C3B31138-FC28-47E7-A0E5-49BAB00BE5E4Q35767718-74962779-8062-4A6B-BE81-F52803DD364BQ35783993-FA504142-1355-4E71-A264-D1FD1A847066Q35824568-56EBC9AB-DD85-4180-A7AF-05F57CEE93D5Q35881504-316C6F27-F0D9-4982-833B-7410F0735CC3Q36441470-D8293189-3C67-40B8-98F3-6FF8EF0EEE5FQ36496770-C7500531-F567-4720-99B0-DDC828F1BA93Q36525382-05E6B4D2-DE44-4FB8-8616-83632708218BQ36652519-C16A42DB-7EC3-4EFE-8143-BD5AEDFE213EQ36682138-AB3F329F-C557-4783-BCBD-31FA1EB8B0F1Q36872748-2A5C5E46-E6F5-4D99-997F-DAFF16425FD1Q37134215-EB922960-F423-4A29-9B74-BE97242F432CQ37358494-CAEE96CD-C3B3-41E3-8275-B26EC6B04832Q37364446-BEB3656E-E467-4056-8B35-257BC801C877Q37368158-B33AB47C-31FB-4D29-BBCD-A7A98BA23A38Q37384407-46B2EE56-CC9A-4BB9-91D5-D078BE8D7873Q37408323-43A63B7E-BF77-4BCA-8B4C-4BD42FC95203Q37412485-83698624-38F3-4192-BA09-3035F3B2BBEDQ37528270-C1AEA861-AB65-4E6C-B07D-A69059E6089EQ37682543-E75A4EC0-A65B-400B-940F-AFC153C3FBBF
P2860
An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3' untranslated region polymorphisms
description
1993 nî lūn-bûn
@nan
1993 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1993 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
name
An apolipoprotein CIII haploty ...... ranslated region polymorphisms
@ast
An apolipoprotein CIII haploty ...... ranslated region polymorphisms
@en
An apolipoprotein CIII haploty ...... ranslated region polymorphisms
@nl
type
label
An apolipoprotein CIII haploty ...... ranslated region polymorphisms
@ast
An apolipoprotein CIII haploty ...... ranslated region polymorphisms
@en
An apolipoprotein CIII haploty ...... ranslated region polymorphisms
@nl
prefLabel
An apolipoprotein CIII haploty ...... ranslated region polymorphisms
@ast
An apolipoprotein CIII haploty ...... ranslated region polymorphisms
@en
An apolipoprotein CIII haploty ...... ranslated region polymorphisms
@nl
P2093
P2860
P356
P1476
An apolipoprotein CIII haploty ...... ranslated region polymorphisms
@en
P2093
J L Breslow
J L Halaas
L A Sandkuijl
M Dammerman
P2860
P304
P356
10.1073/PNAS.90.10.4562
P407
P577
1993-05-15T00:00:00Z